Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Actinomycetota & Inflammatory Bowel Disease (IBD)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Patients with Crohn’s disease respective IBD often exhibit reduced diversity in gut microbial species, typically an increase in Actinomycetota, resulting in dysbiosis
Packey et al. 2009 Curr Opin Infect Dis. 22(3): 292–301.
Cappello & Morreale 2016 Clin. Med. Insights Gastroenterol. 9: 51-62
de Souza & Fiocchi 2016 Nat. Rev. Gastroenterol. Hepatol. 13: 13–27

…

References (Sources)

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases (IBD)
Packey et al. 2009 Curr Opin Infect Dis. 22(3): 292–301.
Immunopathogenesis of IBD: current state of the art
de Souza & Fiocchi 2016 Nat. Rev. Gastroenterol. Hepatol. 13: 13–27
The role of laboratory tests in Crohn’s disease
Cappello & Morreale 2016 Clin. Med. Insights Gastroenterol. 9: 51-62
Review

AI Chat

5/29/2026

Chat with our artificial intelligence:

Start chat!

Actinomycetota & Inflammatory Bowel Disease (IBD)

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat